Can a patient with chronic inflammatory demyelinating polyneuropathy have absent deep‑tendon reflexes while having normal 5/5 strength?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, CIDP Patients Can Be Areflexic with Normal 5/5 Strength

Yes, patients with CIDP can absolutely present with absent deep tendon reflexes while maintaining normal (5/5) muscle strength. This represents the milder end of the CIDP spectrum and is well-documented in the literature.

Clinical Evidence for This Presentation

The research clearly demonstrates that CIDP exists on a spectrum of severity. A study specifically examining "minimal and asymptomatic CIDP" found patients with normal strength in all muscle groups despite absent or reduced tendon reflexes 1. These patients were referred for mild distal paresthesias, had normal strength throughout, yet showed absent tendon jerks (except knee jerks in one patient). Electrophysiology confirmed demyelinating neuropathy, and CSF protein was elevated in all cases 1. This minimal CIDP phenotype represented approximately 8% of their CIDP case series 1.

Why Reflexes Are Lost Before Strength

The dissociation between reflexes and strength occurs because:

  • Reflexes are exquisitely sensitive to demyelination - Even subclinical demyelination significantly prolongs or abolishes reflex arcs before causing clinically detectable weakness
  • Electrophysiologically recorded reflexes show abnormalities even when clinical reflexes appear normal - Studies show that 96% of CIDP patients had abnormal tendon reflex testing even when 7 patients had brisk or normal reflexes on clinical examination 2
  • Absent reflexes are significantly more associated with CIDP than axonal neuropathies 3, making areflexia a sensitive early marker

Clinical Implications and Diagnostic Approach

When you encounter a patient with:

  • Absent or diminished deep tendon reflexes
  • Normal 5/5 strength
  • Mild sensory symptoms (paresthesias, numbness)

You must pursue electrophysiological testing to evaluate for demyelinating polyneuropathy 1. The typical CIDP presentation includes progressive or relapsing symmetric proximal and distal weakness 4, but this minimal variant is well-recognized.

Key Diagnostic Steps:

  • Nerve conduction studies are essential - they will show demyelinating features even with preserved strength 1
  • CSF analysis - expect albuminocytologic dissociation (elevated protein with normal cell count) 1
  • Consider electromyographically recorded reflexes if clinical reflexes seem preserved, as 60% of patients with normal clinical reflexes had abnormal electrophysiological reflexes 5

Common Pitfall to Avoid

Do not dismiss the possibility of CIDP simply because strength is preserved. The absence of weakness does not exclude CIDP, particularly in its early or minimal forms. The combination of areflexia with sensory symptoms warrants full electrodiagnostic evaluation regardless of preserved motor function 1. Delayed diagnosis can lead to progression that might have been prevented with early immunotherapy.

The guideline literature acknowledges "atypical forms of CIDP" 6, and these minimal presentations fall into this category. These patients typically respond well to immunotherapy despite their mild presentation 1.

Related Questions

What are the typical gait characteristics in chronic inflammatory demyelinating polyneuropathy (CIDP)?
In a patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who speaks normally in conversation but develops a severely strangulated voice with absent airflow and phonation on sustained phonation attempts that end in coughing, what is the likely cause and is this a functional (psychogenic) voice disorder?
What are the common triggers or causes of exacerbations of chronic inflammatory demyelinating polyneuropathy (CIDP)?
What are the recommended anesthetic considerations and management for a patient with demyelinating polyneuropathy undergoing surgery?
If a patient has a normal C‑reactive protein level, can they still have chronic inflammatory demyelinating polyneuropathy (CIDP)?
What is the maximum dose of fenofibrate that can be taken together with atorvastatin 80 mg (milligrams) daily?
What are the risks of Movantik (naloxegol) in patients with malignant bowel obstruction?
What is the recommended levofloxacin dose for an adult with multidrug-resistant tuberculosis (MDR‑TB)?
How do I interpret and manage Patient Health Questionnaire‑9 (PHQ‑9) and Generalized Anxiety Disorder‑7 (GAD‑7) scores?
What do low alpha‑1 antitrypsin and low ceruloplasmin indicate in the evaluation of unexplained liver disease?
What are the recommended dosing regimens for pantoprazole (generic) in adults and pediatric patients, including adjustments for severe erosive esophagitis and renal impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.